GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Baolingbao Biology Co Ltd (SZSE:002286) » Definitions » Total Assets

Baolingbao Biology Co (SZSE:002286) Total Assets : ¥2,654 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Baolingbao Biology Co Total Assets?

Baolingbao Biology Co's Total Assets for the quarter that ended in Mar. 2024 was ¥2,654 Mil.

During the past 12 months, Baolingbao Biology Co's average Total Assets Growth Rate was -9.60% per year. During the past 3 years, the average Total Assets Growth Rate was 4.00% per year. During the past 5 years, the average Total Assets Growth Rate was 3.80% per year. During the past 10 years, the average Total Assets Growth Rate was 6.20% per year.

During the past 13 years, Baolingbao Biology Co's highest 3-Year average Total Assets Growth Rate was 21.10%. The lowest was 2.60%. And the median was 9.70%.

Total Assets is connected with ROA %. Baolingbao Biology Co's annualized ROA % for the quarter that ended in Mar. 2024 was 3.49%. Total Assets is also linked to Revenue through Asset Turnover. Baolingbao Biology Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.21.


Baolingbao Biology Co Total Assets Historical Data

The historical data trend for Baolingbao Biology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baolingbao Biology Co Total Assets Chart

Baolingbao Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,518.76 2,630.77 3,029.00 3,006.14 2,658.89

Baolingbao Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,003.53 2,929.22 2,758.38 2,658.89 2,653.61

Baolingbao Biology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Baolingbao Biology Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1983.486+675.407
=2,659

Baolingbao Biology Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=1955.762+697.847
=2,654

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baolingbao Biology Co  (SZSE:002286) Total Assets Explanation

Total Assets is connected with ROA %.

Baolingbao Biology Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=92.672/( (2658.892+2653.609)/ 2 )
=92.672/2656.2505
=3.49 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Baolingbao Biology Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=551.221/( (2658.892+2653.609)/ 2 )
=551.221/2656.2505
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Baolingbao Biology Co Total Assets Related Terms

Thank you for viewing the detailed overview of Baolingbao Biology Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Baolingbao Biology Co (SZSE:002286) Business Description

Traded in Other Exchanges
N/A
Address
NO.1,Dongwaihuan Road, Hi-Tech Development Zone, Yucheng, CHN
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.
Executives
Zhang Guo Gang Directors, executives
Wang Qiang Directors, executives
Huang Yong Qiang Independent director
Jia Wei Chen Supervisors
Zhang Xin Rong Independent director
Liu Zong Li Directors, executives
Liu Feng Directors, executives
Li Xia Directors, executives
Wang Nai Qiang Supervisors
Xue Jian Ping Directors, executives
Yang Yuan Zhi Directors, executives

Baolingbao Biology Co (SZSE:002286) Headlines

No Headlines